Eurobio Scientific launches new proprietary test for the detection of Omicron BA.x, BA.2 and Delta variants of SARS-CoV-2 Routine COVID screening test.
EUROBIO SCIENTIFIC MAKES A MINORITY INVESTMENT IN USENSE, A START-UP DEVELOPPING A MOBILE IN VITRO MEDICAL DEVICE FOR URIANALYSIS With this investment,.
am
Eurobio Scientific (FR0013240934, ALERS, PEA-PME eligible), a leading French group in the field of specialty in vitro medical diagnostics, announces today the availability of its new proprietary
EurobioPlex SARS-CoV-2 SNPs test (EBX-046), a real-time multiplex PCR test for the detection of the SARS-CoV-2 coronavirus and the simultaneous typing of its new mutations.
EBX-046 is a diagnostics test developed and manufactured in France by Eurobio Scientific, allowing, simultaneously in a single well and in a single PCR reaction, the detection on 2 genes of the SARS-CoV-2 virus and the characterization of the three mutations currently in interest: L452R (Californian and Indian variants), E484K (South African and Brazilian variants) and E484Q (Indian variant). The N501Y mutation linked to the British variant is no longer included, since it is now present in more than 85% of cases detected in France. These new mutations are under increasing surveillance as they might be involved i